Tibetan Region Medicine Factory

Tibet Autonomous Region Tibetan Medicine Factory (西藏自治区藏药厂) has its origins in 1916, when the Lhasa Menzi Kang (拉萨门孜康) was founded as a Tibetan medicine production enterprise. Initially part of the Tibetan Hospital (藏医院) in Lhasa, it was later restructured in 2012 into Tibet Ganlu Tibetan Medicine Co., Ltd. (西藏甘露藏药股份有限公司). The factory inherits the traditional Budala Palace (布达拉宫) royal secret production techniques and the Medicine King Mountain (药王山) medicinal traditions, and produces over 54 national-level Tibetan medicines (国药准字号藏药), covering areas like cardiovascular health, digestive systems, and more.

In 2001, it became the first Tibetan medicine enterprise in Tibet to pass GMP certification (Good Manufacturing Practice), and by 2020, the factory’s revenue exceeded 220 million RMB (约2.2亿元). The Ganlu (甘露) brand is recognized as a famous Chinese trademark (中国驰名商标).

Company Overview

  • Founded: 1916 (Lhasa, Tibet)

  • Current Name: Tibet Ganlu Tibetan Medicine Co., Ltd. (西藏甘露藏药股份有限公司)

  • Headquarters: Lhasa (拉萨), Tibet (西藏)

  • Major Products: 54 National-Standard Tibetan Medicines

  • Notable Trademark: Ganlu (甘露), a famous Chinese brand

  • Registered Capital: 200 million RMB (2亿元人民币)

History and Evolution

  • 1916: Lhasa Menzi Kang (拉萨门孜康) is established as a center for both Tibetan medical education and production of Tibetan medicine.

  • 1964: The Lhasa Tibetan Hospital (拉萨市藏医院) establishes a Tibetan medicine factory.

  • 2002: The company is renamed as the Tibet Autonomous Region Tibetan Medicine Factory (西藏自治区藏药厂).

  • 2012: Restructured as Tibet Ganlu Tibetan Medicine Co., Ltd. (西藏甘露藏药股份有限公司), with a registered capital of 200 million RMB.

  • 2021: The company comes under the control of the Tibetan Yuto Tibetan Medicine Industry Group (西藏宇妥藏药产业集团), a subsidiary of Qizheng Tibetan Medicine (奇正藏药).

Products and Certification

  • Tibetan Medicine Products: The factory has over 400 Tibetan medicine formulations, including 54 that have received national drug approval (国药准字号). Of these, 21 are listed in the National Medical Insurance Catalogue (国家医保目录).

  • Key Products: Famous products include Seventy-Taste Pearl Pill (七十味珍珠丸) and Renqing Changjue (仁青常觉), among others.

  • Certifications:

    • In 2001, the company became the first Tibetan medicine enterprise in Tibet to pass the GMP certification.

    • In 2004, the company also received GMP and ISO certifications.

    • The company holds national intangible cultural heritage techniques, such as the Lhasa Beipai Tibetan Medical Mercury Refining Method (拉萨北派藏医水银洗炼法).

Company Honors

  • 2006-2013: Awarded titles such as “Key National Agricultural Leading Enterprise” (农业产业化国家重点龙头企业) and “AAA-level Quality Credit Unit” (AAA级质量信用单位).

  • 2008: Zhuo Pan Lin (卓攀林) awarded as a Chinese Ethnic Medicine Excellent Brand (中国民族医药优秀品牌).

  • 2012: Selected as a designated production enterprise for national ethnic special products (全国民族特需商品定点生产企业).

  • 2024: Ganlu (甘露) brand recognized as one of the third batch of Chinese time-honored brands (第三批中华老字号).

Development Model

  • Business Model: The company utilizes a “Company + Farmers + Base + Technology” model for building medicinal herb demonstration bases (药材示范基地).

  • Revenue: In 2020, the company achieved a revenue of 220 million RMB (2.2亿元人民币).

  • Patents and Technologies: The company holds 18 patents and one national secret technology product.

Current Status

  • Total Assets: Nearly 500 million RMB (约5亿元人民币).

  • Major Areas of Focus: The company continues to excel in Tibetan medicine production, research, and heritage preservation, ensuring the continued development of Tibetan medicinal knowledge.